Literature DB >> 36008565

Current postbiotics in the cosmetic market-an update and development opportunities.

Marco Duarte1, Ana L Oliveira1, Carla Oliveira1, Manuela Pintado1, Ana Amaro1, Ana Raquel Madureira2.   

Abstract

Postbiotics are a new class of health-promoting molecules that derive from probiotics. These new cosmetic and dermatological ingredients are defined as a 'preparation of inanimate microorganisms and/or their components that confers a health benefit on the host'. This review focuses on what is presently known of these compounds, the benefits of using them, the main postbiotics products available in the market and players, the production key trends and available production methods. The main advantages identified for the use of postbiotics are related to their higher specificity of action on resident microbiota as of interaction with cells of the host compared to probiotics. Postbiotics can be produced/obtained especially through fermentative processes, but most of companies industrial processes are patented. Most of these compounds are usually derived from lactic acid bacteria, Lactobacillus genera and/or yeasts, especially Saccharomyces cerevisiae. Postbiotics go from metabolites like teichoic acids to polysaccharides among others and exhibit important biological properties such as antioxidant, anti-inflammatory, anti-proliferative and immunomodulatory-the reason why their use in cosmetic formulations must be considered. Besides that, when compared to probiotics, postbiotics have longer shelf life and greater safety and do not require viability in the topical formulation which turns them into an innovative approach within the cosmetic ingredients market. The main players are companies that operate in several areas, such as the chemical industry, food innovation, pharmaceutical and cosmetic industries, and the critical trends for production of these compounds include energy efficiency, emission-free mobility, conservation of finite resources and renewable raw material utilization. KEY POINTS: • Postbiotics are mainly derived from lactic acid bacteria and S. cerevisiae. • Postbiotics exhibit several biological properties. • Postbiotics present several advantages over probiotics.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cosmetic(s); Fermentation; Lactobacillus; Postbiotic(s); Probiotic(s); Saccharomyces

Mesh:

Year:  2022        PMID: 36008565     DOI: 10.1007/s00253-022-12116-5

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   5.560


  31 in total

1.  Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation.

Authors:  Han Geun Kim; Seung Yeon Lee; Na Ra Kim; Hea Young Lee; Mi Yeon Ko; Bong Jun Jung; Chul Min Kim; Jung Min Lee; Jong Hwan Park; Seung Hyun Han; Dae Kyun Chung
Journal:  Mol Immunol       Date:  2010-12-03       Impact factor: 4.407

2.  Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.

Authors:  Colin Hill; Francisco Guarner; Gregor Reid; Glenn R Gibson; Daniel J Merenstein; Bruno Pot; Lorenzo Morelli; Roberto Berni Canani; Harry J Flint; Seppo Salminen; Philip C Calder; Mary Ellen Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-06-10       Impact factor: 46.802

3.  Protective Role of Postbiotic Mediators Secreted by Lactobacillus rhamnosus GG Versus Lipopolysaccharide-induced Damage in Human Colonic Smooth Muscle Cells.

Authors:  Alessia Cicenia; Floriana Santangelo; Lucrezia Gambardella; Lucia Pallotta; Valerio Iebba; Annunziata Scirocco; Massimo Marignani; Guglielmo Tellan; Marilia Carabotti; Enrico Stefano Corazziari; Serena Schippa; Carola Severi
Journal:  J Clin Gastroenterol       Date:  2016 Nov/Dec       Impact factor: 3.062

4.  Lactobacillus rhamnosus cell lysate in the management of resistant childhood atopic eczema.

Authors:  Ba X Hoang; Graeme Shaw; Phuong Pham; Stephen A Levine
Journal:  Inflamm Allergy Drug Targets       Date:  2010-07

5.  Novel solid-state fermentation of bee-collected pollen emulating the natural fermentation process of bee bread.

Authors:  Raffaella Di Cagno; Pasquale Filannino; Vincenzo Cantatore; Marco Gobbetti
Journal:  Food Microbiol       Date:  2019-02-14       Impact factor: 5.516

6.  Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis.

Authors:  Stephen B Freedman; Sarah Williamson-Urquhart; Ken J Farion; Serge Gouin; Andrew R Willan; Naveen Poonai; Katrina Hurley; Philip M Sherman; Yaron Finkelstein; Bonita E Lee; Xiao-Li Pang; Linda Chui; David Schnadower; Jianling Xie; Marc Gorelick; Suzanne Schuh
Journal:  N Engl J Med       Date:  2018-11-22       Impact factor: 91.245

7.  Application of the biorefinery concept to produce L-lactic acid from the soybean vinasse at laboratory and pilot scale.

Authors:  Susan G Karp; Adriana H Igashiyama; Paula F Siqueira; Júlio C Carvalho; Luciana P S Vandenberghe; Vanete Thomaz-Soccol; Jefferson Coral; Jean-Luc Tholozan; Ashok Pandey; Carlos R Soccol
Journal:  Bioresour Technol       Date:  2010-10-08       Impact factor: 9.642

8.  Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect.

Authors:  Bong Seon Kang; Jae-Gu Seo; Gwa-Su Lee; Jung-Hwa Kim; Sei Yeon Kim; Ye Won Han; Hoon Kang; Hyung Ok Kim; Ji Hwan Rhee; Myung-Jun Chung; Young Min Park
Journal:  J Microbiol       Date:  2009-02-20       Impact factor: 3.422

9.  Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities.

Authors:  Alberto Amaretti; Mattia di Nunzio; Anna Pompei; Stefano Raimondi; Maddalena Rossi; Alessandra Bordoni
Journal:  Appl Microbiol Biotechnol       Date:  2012-07-12       Impact factor: 4.813

Review 10.  Skin microbiome transplantation and manipulation: Current state of the art.

Authors:  Chris Callewaert; Nastassia Knödlseder; Ante Karoglan; Marc Güell; Bernhard Paetzold
Journal:  Comput Struct Biotechnol J       Date:  2021-01-04       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.